ArticleMolecular systems biology2026
VEFill: accurate and generalizable deep mutational scanning score imputation across protein domains.
Article in Molecular systems biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
Deep Mutational Scanning (DMS) assays can systematically assess the effects of amino acid substitutions on protein function, but many datasets have incomplete variant coverage due to technical constraints. We developed VEFill (Variant Effect Fill), a gradient boosting model for imputing missing DMS scores across protein domains. Trained on the Human Domainome 1, VEFill integrates ESM-1v sequence embeddings, evolutionary conservation (EVE scores), amino acid substitution matrices, and physicochemical descriptors. The model achieved robust predictive performance (Pearson r = 0.80) and generalized reliably to unseen proteins in stability-based datasets, while showing weaker performance on activity-based assays. Per-protein models confirmed VEFill's effectiveness under limited-data conditions and a reduced two-feature version performed comparably to the full model, suggesting an efficient alternative. Across multiple benchmarking settings, VEFill consistently outperformed baselines once ≥20% of experimental measurements were available. However, true zero-shot prediction without positional context remains challenging, particularly for functionally complex proteins. Overall, VEFill offers an interpretable, scalable framework for DMS score imputation, and enables systematic mutation prioritization including the design of sparse experimental libraries for variant effect studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.